1. Cell Biology

Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes

  1. Terje R Kolstad
  2. Jonas van den Brink
  3. Niall MacQuaide
  4. Per Kristian Lunde
  5. Michael Frisk
  6. Jan Magnus Aronsen
  7. Einar Sjaastad Norden
  8. Alessandro Cataliotti
  9. Ivar Sjaastad
  10. Ole Mathias Sejersted
  11. Andrew G Edwards
  12. Glenn Terje Lines
  13. William Edward Louch  Is a corresponding author
  1. Oslo University Hospital, Norway
  2. Simula Reseach Laboratory, Norway
  3. University of Glasgow, United Kingdom
  4. Simula Research Laboratory, Norway
https://doi.org/10.7554/eLife.39427
Share this article
Cite this article
  1. Terje R Kolstad
  2. Jonas van den Brink
  3. Niall MacQuaide
  4. Per Kristian Lunde
  5. Michael Frisk
  6. Jan Magnus Aronsen
  7. Einar Sjaastad Norden
  8. Alessandro Cataliotti
  9. Ivar Sjaastad
  10. Ole Mathias Sejersted
  11. Andrew G Edwards
  12. Glenn Terje Lines
  13. William Edward Louch
(2018)
Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes
eLife 7:e39427.
https://doi.org/10.7554/eLife.39427
  2. Download BibTeX
  3. Download .RIS

Abstract

Reduced cardiac contractility during heart failure (HF) is linked to impaired Ca2+ release from Ryanodine Receptors (RyRs). We investigated whether this deficit can be traced to nanoscale RyR reorganization. Using super-resolution imaging, we observed dispersion of RyR clusters in cardiomyocytes from post-infarction HF rats, resulting in more numerous, smaller clusters. Functional groupings of RyR clusters which produce Ca2+ sparks (Ca2+ release units, CRUs) also became less solid. An increased fraction of small CRUs in HF was linked to augmented 'silent' Ca2+ leak, not visible as sparks. Larger multi-cluster CRUs common in HF also exhibited low fidelity spark generation. When successfully triggered, sparks in failing cells displayed slow kinetics as Ca2+ spread across dispersed CRUs. During the action potential, these slow sparks protracted and desynchronized the overall Ca2+ transient. Thus, nanoscale RyR reorganization during HF augments Ca2+ leak and slows Ca2+ release kinetics, leading to weakened contraction in this disease.

Data availability

Source data files have been provided for Figures 2 , 4 and 6.All raw data acquired and analyzed in this study are publicly available in the following repository: https://github.com/TerjePrivate/Ryanodine_Receptor_Dispersion_during_Heart_Failure

Article and author information

Author details

  1. Terje R Kolstad

    Insitute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0589-5689

  2. Jonas van den Brink

    Simula Reseach Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.

  3. Niall MacQuaide

    Institute of Cardiovascular Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  4. Per Kristian Lunde

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  5. Michael Frisk

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  6. Jan Magnus Aronsen

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  7. Einar Sjaastad Norden

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  8. Alessandro Cataliotti

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  9. Ivar Sjaastad

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.

  10. Ole Mathias Sejersted

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8817-3296

  11. Andrew G Edwards

    Simula Research Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.

  12. Glenn Terje Lines

    Simula Research Laboratory, Fornebu, Norway
    Competing interests
    The authors declare that no competing interests exist.

  13. William Edward Louch

    Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway
    For correspondence
    w.e.louch@medisin.uio.no
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0511-6112

Funding

Horizon 2020 Framework Programme (Consolidator grant for WEL 647714)

  • Terje R Kolstad
  • William Edward Louch

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were approved by the Norwegian National Animal Research Authority (project license no. FOTS 5982, 7786), and were performed in accordance with the National Institute of Health guidelines (NIH publication No. 85-23, revised 2011) and European Directive 2010/63/EU.

Copyright

© 2018, Kolstad et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,076
    views
  • 455
    downloads
  • 97
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Citations by DOI

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Terje R Kolstad
  2. Jonas van den Brink
  3. Niall MacQuaide
  4. Per Kristian Lunde
  5. Michael Frisk
  6. Jan Magnus Aronsen
  7. Einar Sjaastad Norden
  8. Alessandro Cataliotti
  9. Ivar Sjaastad
  10. Ole Mathias Sejersted
  11. Andrew G Edwards
  12. Glenn Terje Lines
  13. William Edward Louch
(2018)
Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes
eLife 7:e39427.
https://doi.org/10.7554/eLife.39427

Share this article

https://doi.org/10.7554/eLife.39427

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Prolonged β-adrenergic stimulation disperses ryanodine receptor clusters in cardiomyocytes and has implications for heart failure

    Xin Shen, Jonas van den Brink ... William E Louch
    Research Advance Updated

    Ryanodine receptors (RyRs) exhibit dynamic arrangements in cardiomyocytes, and we previously showed that ‘dispersion’ of RyR clusters disrupts Ca2+ homeostasis during heart failure (HF) (Kolstad et al., eLife, 2018). Here, we investigated whether prolonged β-adrenergic stimulation, a hallmark of HF, promotes RyR cluster dispersion and examined the underlying mechanisms. We observed that treatment of healthy rat cardiomyocytes with isoproterenol for 1 hr triggered progressive fragmentation of RyR clusters. Pharmacological inhibition of Ca2+/calmodulin-dependent protein kinase II (CaMKII) reversed these effects, while cluster dispersion was reproduced by specific activation of CaMKII, and in mice with constitutively active Ser2814-RyR. A similar role of protein kinase A (PKA) in promoting RyR cluster fragmentation was established by employing PKA activation or inhibition. Progressive cluster dispersion was linked to declining Ca2+ spark fidelity and magnitude, and slowed release kinetics from Ca2+ propagation between more numerous RyR clusters. In healthy cells, this served to dampen the stimulatory actions of β-adrenergic stimulation over the longer term and protect against pro-arrhythmic Ca2+ waves. However, during HF, RyR dispersion was linked to impaired Ca2+ release. Thus, RyR localization and function are intimately linked via channel phosphorylation by both CaMKII and PKA, which, while finely tuned in healthy cardiomyocytes, underlies impaired cardiac function during pathology.